Financial News
Articles published by Spectrum Pharmaceuticals
Spectrum Pharmaceuticals Announces New Employment Inducement Grant for Commercial Staff
January 26, 2023
Via Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Announces New Employment Inducement Grants for Commercial Staff
December 05, 2022
Via Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Provides Update on Poziotinib Following FDA Oncologic Drugs Advisory Committee Meeting
September 22, 2022
Via Business Wire
Tickers
SPPI
Via Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Announces Acceptance of New Drug Application Filing for Poziotinib
February 11, 2022
Via Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals to Participate in B. Riley Securities 2022 Virtual Oncology Conference
January 20, 2022
Via Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Announces Strategic Restructuring
January 05, 2022
Via Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Submits New Drug Application for Poziotinib
December 06, 2021
Via Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals to Participate in JMP Securities Hematology and Oncology Summit
November 30, 2021
Via Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals to Participate in 2021 Jefferies London Healthcare Conference
November 11, 2021
Via Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals to Report Third Quarter 2021 Financial Results and Provide Corporate Update
November 03, 2021
Via Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals to Participate in 2021 Cantor Virtual Global Healthcare Conference
September 22, 2021
Via Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Receives Complete Response Letter from FDA for ROLONTIS® (eflapegrastim)
August 06, 2021
Via Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals to Report Second Quarter 2021 Financial Results and Provide Corporate Update
August 05, 2021
Via Business Wire
Tickers
SPPI
Via Business Wire
Tickers
SPPI
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.